PF-07321332/Ritonavir Oral Powder (nirmatrelvir/ritonavir)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for PF-07321332/Ritonavir Oral Powder (nirmatrelvir/ritonavir), covering 2024-06-06 to 2024-06-06. Get the full timeline:
Most recent: Clinical Trial Update: Relative Bioavailability Study of PF-07321332/Ritonavir Oral Powder Relative to the Commercial Tablets in Healthy Participants [Phase 1]